The future of prognostic factors in outcome prediction for patients with cancer
- 1 November 1992
- Vol. 70 (9) , 2367-2377
- https://doi.org/10.1002/1097-0142(19921101)70:9<2367::aid-cncr2820700927>3.0.co;2-b
Abstract
The anatomic description of the extent of tumor spread (tumor staging) assists clinical management, facilitates communication among physicians, is an essential part of randomized controlled trials, and may help in the counseling patients and their families. However, in recent years, additional “prognostic factors” have been defined, many of which assess or reflect the biologic behavior of malignant neoplasms. Other measures of tumor biochemistry address the natural history of neoplastic development and often are included in a discussion of new prognostic factors. This review article summarizes current knowledge and thinking related to tumor prognostic factors in four areas by providing: (1) a definition and principles of anatomic spread of tumor (staging) and some suggestions for improvement, (2) a description of some examples of additional factors of prognostic significance, (3) some statistical methods to evaluate prognostic factors, and (4) an examination of the possible future of summary statements of outcome (i.e., prognostic indexes). Cancer 1992; 70:2367-2377.Keywords
This publication has 69 references indexed in Scilit:
- Selection of appropriate cellular and molecular biologic diagnostic tests in the evaluation of cancerCancer, 1992
- Prognostic grouping: the next step in tumor classificationZeitschrift für Krebsforschung und Klinische Onkologie, 1990
- Improved Detection of Metastases to Lymph Nodes and Estrogen Receptor DeterminationArchives of Surgery, 1990
- Detection of lymph node metastases in colorectal carcinoma before and after fat clearanceBritish Journal of Surgery, 1989
- Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patientsCancer, 1989
- Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.Proceedings of the National Academy of Sciences, 1987
- Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significanceBritish Journal of Cancer, 1987
- Histopathology reporting in large bowel cancer.Journal of Clinical Pathology, 1981
- Significance of Axillary Macrometastases and Micrometastases in Mammary CancerAnnals of Surgery, 1971
- Significance of occult metastases.A study of breast cancerCancer, 1961